 |
市場調査レポート
商品コード
1463430
血液スクリーニングの世界市場規模、シェア、成長分析、製品タイプ別、エンドユーザー別 - 産業予測、2024～2031年Global Blood Screening Market Size, Share, Growth Analysis, By Product Type(Reagents & Kits, Instruments), By End User(Hospitals & Clinics, Blood Banks) - Industry Forecast 2024-2031 |
||||||
| 血液スクリーニングの世界市場規模、シェア、成長分析、製品タイプ別、エンドユーザー別 - 産業予測、2024～2031年 |
|
出版日: 2024年04月10日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の血液スクリーニングの市場規模は、2022年に27億3,000万米ドルとなり、予測期間（2024～2031年）のCAGRは8.50%で、2023年の29億6,000万米ドルから、2031年までには56億9,000万米ドルに成長する見通しです。
血液スクリーニング用の自動分子プラットフォームは、業界をリードする企業間で人気が高まっており、市場拡大を牽引しています。血液スクリーニング市場の成長は、献血数や献血者数の増加、献血血液の安全性に関する意識の高まり、感染症の急増、さまざまな政府の取り組みなど、いくつかの重要な要因によって促進されています。2021年12月の記事「手術リスク」によると、世界中で年間2億3,400万件を超える大手術が実施されており、この急増はさらに後押しされています。さらに、小児急性貧血、外傷、先天性母体血液異常などの問題に対処するため、困難な出産では輸血が頻繁に行われます。さらに、2021年6月の世界保健機関（WHO）ファクトシートのデータによると、世界では1億1,850万件の献血が行われており、その40％は高所得国からです。注目すべきは、所得水準に対する献血の割合で、高所得国が31.5％、上位中所得国が15.9％、下位中所得国が6.8％、低所得国が5.0％となっており、格差が浮き彫りになっています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要な投資の分析
- 主要な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
血液スクリーニングの世界市場：製品タイプ別
- 市場概要
- 試薬・キット
- 機器
- ソフトウェア
血液スクリーニングの世界市場：エンドユーザー別
- 市場概要
- 病院・クリニック
- 血液銀行
- 診断センター
- 研究所
血液スクリーニングの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Abbott Laboratories（USA）
- Becton, Dickinson and Company（USA）
- Bio-Rad Laboratories, Inc.（USA）
- bioMA（C）rieux SA（France）
- F. Hoffmann-La Roche Ltd.（Switzerland）
- Grifols, S.A.（Spain）
- Hologic, Inc.（USA）
- Immucor, Inc.（USA）
- Meridian Bioscience, Inc.（USA）
- Ortho Clinical Diagnostics（USA）
- Quotient Limited（UK）
- Siemens Healthineers AG（Germany）
- Sysmex Corporation（Japan）
- Thermo Fisher Scientific Inc.（USA）
- Danaher Corporation（USA）
- Grifols Diagnostic Solutions Inc.（USA）
- Haemonetics Corporation（USA）
- Luminex Corporation（USA）
- Natera, Inc.（USA）
- Novartis International AG（Switzerland）
- PerkinElmer, Inc.（USA）
- Promega Corporation（USA）
Global Blood Screening Market size was valued at USD 2.73 Billion in 2022 and is poised to grow from USD 2.96 Billion in 2023 to USD 5.69 Billion by 2031, at a CAGR of 8.50% during the forecast period (2024-2031).
Automated molecular platforms for Blood Screening have become increasingly popular among leading industry players, driving market expansion. The growth of the Blood Screening market is fueled by several key factors including the escalating number of blood donations and donors, heightened awareness regarding the safety of donated blood, the surge in infectious diseases, and various governmental initiatives. This surge is further bolstered by the staggering volume of major surgeries conducted worldwide annually, surpassing 234 million according to the December 2021 article "Operative Risk". Additionally, blood transfusions are frequently administered in challenging childbirths to address issues like childhood acute anaemia, trauma, and congenital maternal blood abnormalities. Furthermore, data from the World Health Organization (WHO) Factsheet of June 2021 indicates that 118.5 million blood donations are made globally, with 40% originating from high-income countries, despite these countries only representing 16% of global blood donations. Notably, the proportion of donations relative to income levels highlights disparities, with high-income nations contributing 31.5%, upper-middle-income nations 15.9%, lower-middle-income nations 6.8%, and low-income nations 5.0%.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Screening Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Blood Screening Market Segmental Analysis
Global Blood Screening Market is segmented on the basis of product type, end users and region. By product type, the market is segmented into reagents & kits, instruments, software. By end user, the market is segmented into hospitals & clinics, blood banks, diagnostic centers, and research laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Blood Screening Market
Healthcare professionals and patients are increasingly recognizing the potential dangers linked with blood transfusions, including the transmission of infectious diseases. Consequently, there is a rising need for blood screening products that guarantee the safety of both blood and blood-related products.
Restraints in the Global Blood Screening Market
The scarcity of phlebotomists, laboratory technicians, and other skilled workers in the industry could impede the widespread adoption of blood screening products. Healthcare institutions and blood banks may encounter difficulties in finding qualified personnel to operate the equipment and conduct tests, potentially limiting their ability to implement comprehensive blood screening programs.
Market Trends of the Global Blood Screening Market
The increasing demand for plasma-derived products like immunoglobulins and clotting factors is fueling the need for advanced blood screening tools to guarantee the safety of these products. This upward trajectory is projected to persist as the utilization of plasma-derived products extends into emerging therapeutic domains.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Blood Screening Market by Product Type
- Market Overview
- Reagents & Kits
- Instruments
- Software
Global Blood Screening Market by End User
- Market Overview
- Hospitals & Clinics
- Blood Banks
- Diagnostic Centers
- Research Laboratories
Global Blood Screening Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- bioMA(C)rieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Immucor, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meridian Bioscience, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ortho Clinical Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quotient Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Grifols Diagnostic Solutions Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Haemonetics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natera, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
